Picture of Q32 Bio logo

QTTB — Q32 Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSuper Stock

Brief: Homology Medicines Inc Currently Estimates That It Will Incur Approximately $6.8 Million In Charges In Connection With Reduction In Force

July 27 (Reuters) - Homology Medicines Inc  FIXX.O :
    * HOMOLOGY MEDICINES INC - CURRENTLY ESTIMATES THAT IT WILL
INCUR
APPROXIMATELY $6.8 MILLION IN CHARGES IN CONNECTION WITH
REDUCTION IN FORCE
    * HOMOLOGY MEDICINES INC - EXPECTS THAT MAJORITY OF CHARGES
RELATED TO REDUCTION IN FORCE WILL BE INCURRED IN Q3 OF 2023


Further company coverage:  FIXX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Q32 Bio

See all news